Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01528761 · ClinicalTrials.gov registry record · NA
Prosocial Behavior and Volunteerism to Promote Physical Activity in Older Adults
A NA study, sponsored by Wake Forest University Health Sciences.
- Completed
- Registry status
- NA
- Development phase
- 317
- Enrollment target
NCT01528761: Completed NA study, sponsored by Wake Forest University Health Sciences.
NCT01528761 is a NA study that has completed, run by Wake Forest University Health Sciences. The registered enrollment target is 317 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (77% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01528761, a NA study, has completed, sponsored by Wake Forest University Health Sciences.
- COMPLETED
- Registry status
- NA
- Development phase
- 317 participants
- Enrollment target
Study Summary
The purpose of this 12-month study is to compare how well two programs help older adults make physical activity a regular habit.
Primary Outcome
Self-reported physical activity will be assessed using a questionnaire at 4 time points among all participants; (1) at baseline before randomization; (2) 3 months after the interventions begin; (3) 6 months after the interventions begin; and (4) 12 months after the interventions begin
Interventions
- BEHAVIORAL Prosocial Behavior Physical Activity (PBPA)
- OTHER Healthy Aging (HA)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 317 participants |
| Start Date | 2011-08-15 |
| Est. Completion | 2017-03-28 |
| Phase | NA |
What the finished NCT01528761 record still lists
NCT01528761 is an interventional study that assigns participants to a tested intervention. The registered 317 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (77% lower).
The record links to 0 conditions, and to 2 interventions - of which Prosocial Behavior Physical Activity (PBPA) is the first listed.
NCT01528761 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01528761 about?
NCT01528761 is a clinical study titled "Prosocial Behavior and Volunteerism to Promote Physical Activity in Older Adults". The purpose of this 12-month study is to compare how well two programs help older adults make physical activity a regular habit.
What is the current status of trial NCT01528761?
This trial is currently completed. It is a NA study. The enrollment target is 317 participants. The study started on 2011-08-15. Estimated completion is 2017-03-28.
What interventions are being tested in trial NCT01528761?
The interventions under investigation include: Prosocial Behavior Physical Activity (PBPA) (BEHAVIORAL), Healthy Aging (HA) (OTHER).
Who is sponsoring clinical trial NCT01528761?
This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01528761's enrollment target sits among peer trials
317 321st of 2000 higher than 1,680 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04594642 · 317 participants · Phase 1
A Study of AZD0486 in Subjects With B-Cell Non-Hodgkin Lymphoma
- NCT04977453 · 317 participants · Phase 1
GI-101/GI-101A as a Single Agent or in Combination With Pembrolizumab or Lenvatinib in Advanced Solid Tumors
- NCT05137054 · 317 participants · Phase 1
A Study to Examine the Effects of Novel Therapy Linvoseltamab in Combination With Other Cancer Treatments for Adult Patients With Multiple Myeloma That is Resistant to Current Standard of Care Treatments
- NCT05382754 · 317 participants · NA
Home Apnea Testing in CHildren Trial
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI